SML0115
MDL 11939
≥98% (HPLC)
别名:
α-Phenyl-1-(2-phenylethyl)-4-piperidinemethanol, Glemanserin, MDL11939
登录 查看组织和合同定价。
选择规格
变更视图
关于此项目
经验公式（希尔记法）:
C20H25NO
化学文摘社编号:
分子量:
295.42
NACRES:
NA.77
PubChem Substance ID:
UNSPSC Code:
12352200
MDL number:
Assay:
≥98% (HPLC)
Form:
powder
assay
≥98% (HPLC)
form
powder
color
white to tan
solubility
DMSO: ≥8 mg/mL
originator
Sanofi Aventis
storage temp.
2-8°C
SMILES string
OC(C1CCN(CCC2=CC=CC=C2)CC1)C3=CC=CC=C3
InChI
1S/C21H27NO/c23-21(19-11-5-2-6-12-19)20-13-16-22(17-14-20)15-7-10-18-8-3-1-4-9-18/h1-6,8-9,11-12,20-21,23H,7,10,13-17H2
InChI key
CTDVLAJTGZQELM-UHFFFAOYSA-N
Biochem/physiol Actions
Potent, selective, and orally active 5-HT2 receptor antagonist (ASTAR)
MDL 11,939 is a potent, selective and orally active 5-HT2 receptor antagonist (ASTAR). Ki values values are in the low nanomolar range for 5-HT2A with over 100-fold selectivity over 5-HT2C receptors and low or no affinity for non-5-HT2 receptors or transporters.
Features and Benefits
This compound was developed by Sanofi Aventis. To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here.
signalword
Warning
hcodes
pcodes
Hazard Classifications
Aquatic Acute 1
存储类别
11 - Combustible Solids
wgk
WGK 3
flash_point_f
Not applicable
flash_point_c
Not applicable